These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18946759)

  • 1. Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.
    Kawaguchi W; Itamochi H; Kigawa J; Kanamori Y; Oishi T; Shimada M; Sato S; Sato S; Terakawa N
    Int J Clin Oncol; 2008 Oct; 13(5):461-3. PubMed ID: 18946759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage III malignant mixed Müllerian tumor of the fallopian tube: a case of 5-year survival after optimal debulking and adjuvant chemotherapy with paclitaxel plus carboplatin.
    Tsai CP; Ho ES; Ke YM; Hsu ST; Wang RC; Lu CH
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):294-6. PubMed ID: 22795114
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant mixed Müllerian tumor of the fallopian tube: a case report.
    Watanabe T; Sugino T; Furukawa S; Soeda S; Nishiyama H; Fujimori K
    Eur J Gynaecol Oncol; 2012; 33(2):223-6. PubMed ID: 22611970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage I primary malignant mixed müllerian tumor of the fallopian tube. Report of a case with five-year survival after minimal surgery without adjuvant treatment.
    Ebert AD; Perez-Canto A; Schaller G; Entezami M; Hopp HS; Weitzel HK
    J Reprod Med; 1998 Jul; 43(7):598-600. PubMed ID: 9693413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant mixed müllerian tumor of the fallopian tube.
    Zorlu CG; Cobanoglu O; Kuşçu E; Aribas D
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):352-4. PubMed ID: 8160547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors.
    Matulonis UA; Krag KJ; Krasner CN; Atkinson T; Horowitz NS; Lee H; Penson RT
    Gynecol Oncol; 2009 Feb; 112(2):394-9. PubMed ID: 19058838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of fallopian tube carcinoma.
    Gadducci A
    Curr Opin Obstet Gynecol; 2002 Feb; 14(1):27-32. PubMed ID: 11801873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary malignant mixed Müllerian tumor of the fallopian tube after subtotal hysterectomy: a case report and literature review.
    Ji J; Zuo P; Li L; Wang Y
    Arch Gynecol Obstet; 2015 May; 291(5):1187-90. PubMed ID: 25588328
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.
    Scholz HS; Lax S; Tamussino KF; Benedicic C; Petru E
    Anticancer Res; 2000; 20(6C):4801-2. PubMed ID: 11205221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility study of neoadjuvant chemotherapy followed by interval debulking surgery for stage III/IV ovarian, tubal, and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0206.
    Onda T; Kobayashi H; Nakanishi T; Hatae M; Iwasaka T; Konishi I; Shibata T; Fukuda H; Kamura T; Yoshikawa H
    Gynecol Oncol; 2009 Apr; 113(1):57-62. PubMed ID: 19181369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Undifferentiated Carcinoma of the Sigmoid Colon That Responded to Paclitaxel and Carboplatin Chemotherapy].
    Toyama S; Kudoh K; Ohnuma S; Sato S; Tanaka N; Aoki T; Imoto H; Karasawa H; Watanabe K; Nagao M; Abe T; Musha H; Motoi F; Naitoh T; Unno M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2295-2297. PubMed ID: 28133300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature.
    Duman BB; Kara IO; Günaldi M; Ercolak V
    Arch Gynecol Obstet; 2011 Jun; 283(6):1363-8. PubMed ID: 21298439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-based chemotherapy in carcinoma of the fallopian tube.
    Gemignani ML; Hensley ML; Cohen R; Venkatraman E; Saigo PE; Barakat RR
    Gynecol Oncol; 2001 Jan; 80(1):16-20. PubMed ID: 11136563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant mixed Mullerian tumor of the fimbriated end of the fallopian tube: origin as an intraepithelial carcinoma.
    Gagner JP; Mittal K
    Gynecol Oncol; 2005 Apr; 97(1):219-22. PubMed ID: 15790462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for malignant mixed Müllerian tumors of the ovary.
    Sit AS; Price FV; Kelley JL; Comerci JT; Kunschner AJ; Kanbour-Shakir A; Edwards RP
    Gynecol Oncol; 2000 Nov; 79(2):196-200. PubMed ID: 11063643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report.
    Kuji S; Kondo H; Ohara T; Deura I; Tozawa-Ono A; Migita O; Kawamoto H; Tsugawa K; Chosokabe M; Koike J; Maeda I; Suzuki N
    Jpn J Clin Oncol; 2021 Mar; 51(3):492-497. PubMed ID: 33377156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colon stenosis in a patient with ulcerative colitis as a manifestation of mixed müllerian tumor of the peritoneum.
    Magro F; Pereira P; Carneiro F; Lopes JM; Teixeira A; Sarmento C; Lima J; Saraiva A; Teixeira A; Tavarela-Veloso F
    Scand J Gastroenterol; 2005 Oct; 40(10):1251-4. PubMed ID: 16265782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
    du Bois A; Kristensen G; Ray-Coquard I; Reuss A; Pignata S; Colombo N; Denison U; Vergote I; Del Campo JM; Ottevanger P; Heubner M; Minarik T; Sevin E; de Gregorio N; Bidziński M; Pfisterer J; Malander S; Hilpert F; Mirza MR; Scambia G; Meier W; Nicoletto MO; Bjørge L; Lortholary A; Sailer MO; Merger M; Harter P;
    Lancet Oncol; 2016 Jan; 17(1):78-89. PubMed ID: 26590673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant mixed müllerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer: case report and literature review.
    Ma CJ; Yang SF; Huang CC; Chai CY; Cheng KI; Tsai EM; Wang JY
    Eur J Gynaecol Oncol; 2008; 29(3):289-93. PubMed ID: 18592799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.
    Duska LR; Garrett A; Eltabbakh GH; Oliva E; Penson R; Fuller AF
    Gynecol Oncol; 2002 Jun; 85(3):459-63. PubMed ID: 12051874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.